These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 1366242)
1. TSH as an index of L-thyroxine replacement and suppression therapy. Igoe D; Duffy MJ; McKenna TJ Ir J Med Sci; 1992 Dec; 161(12):684-6. PubMed ID: 1366242 [TBL] [Abstract][Full Text] [Related]
2. Free thyroxine, free triiodothyronine, and thyrotropin concentrations in hypothyroid and thyroid carcinoma patients receiving thyroxine therapy. Liewendahl K; Helenius T; Lamberg BA; Mähönen H; Wägar G Acta Endocrinol (Copenh); 1987 Nov; 116(3):418-24. PubMed ID: 3687325 [TBL] [Abstract][Full Text] [Related]
3. Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyroidism. Shimon I; Cohen O; Lubetsky A; Olchovsky D Thyroid; 2002 Sep; 12(9):823-7. PubMed ID: 12481949 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine. Koulouri O; Auldin MA; Agarwal R; Kieffer V; Robertson C; Falconer Smith J; Levy MJ; Howlett TA Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256 [TBL] [Abstract][Full Text] [Related]
5. Plasma free thyroxine concentrations in patients receiving levothyroxine for thyroid suppression. Hughes JM; Gallagher DL; Olson JE Surgery; 1989 Dec; 106(6):951-5. PubMed ID: 2588121 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the nocturnal serum thyrotropin (TSH) surge, as assessed by TSH ultrasensitive assay, in patients receiving long term L-thyroxine suppression therapy and in patients with various thyroid disorders. Bartalena L; Martino E; Falcone M; Buratti L; Grasso L; Mammoli C; Pacchiarotti A; Aghini-Lombardi F; Balzano S; Pinchera A J Clin Endocrinol Metab; 1987 Dec; 65(6):1265-71. PubMed ID: 3680483 [TBL] [Abstract][Full Text] [Related]
7. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH. Persani L; Preziati D; Matthews CH; Sartorio A; Chatterjee VK; Beck-Peccoz P Clin Endocrinol (Oxf); 1997 Aug; 47(2):207-14. PubMed ID: 9302396 [TBL] [Abstract][Full Text] [Related]
8. Factors affecting suppression of endogenous thyrotropin secretion by thyroxine treatment: retrospective analysis in athyreotic and goitrous patients. Bartalena L; Martino E; Pacchiarotti A; Grasso L; Aghini-Lombardi F; Buratti L; Bambini G; Breccia M; Pinchera A J Clin Endocrinol Metab; 1987 Apr; 64(4):849-55. PubMed ID: 3818906 [TBL] [Abstract][Full Text] [Related]
9. Free thyroid hormones and a third-generation TSH assay in the detection of hyperthyroidism during long-term thyroxine treatment in thyroid carcinoma patients. Taimela E; Koskinen P; Nuutila P; Nikkanen V; Saraste M; Taimela S; Irjala K Scand J Clin Lab Invest; 1995 Apr; 55(2):181-6. PubMed ID: 7667611 [TBL] [Abstract][Full Text] [Related]
10. Acute effect of exogenous thyroxine dose on serum thyroxine and thyrotrophin levels in treated hypothyroid patients. Soppi E; Irjala K; Kaihola HL; Viikari J Scand J Clin Lab Invest; 1984 Jun; 44(4):353-6. PubMed ID: 6463564 [TBL] [Abstract][Full Text] [Related]
11. Changes in circulating thyroid hormone levels and systolic time intervals in acute hypothyroidism. Price DE; O'Malley BP; Northover B; Rosenthal FD Clin Endocrinol (Oxf); 1991 Jul; 35(1):67-9. PubMed ID: 1889141 [TBL] [Abstract][Full Text] [Related]
12. Studies on replacement and suppressive dosages of 1-thyroxine. Nilsson G; Pettersson U; Levin K; Hughes R Acta Med Scand; 1977; 202(4):257-60. PubMed ID: 920242 [TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the optimal thyroxine dose with the TRH test for replacement and suppression therapy]. Erne P; Staub JJ; Althaus B; Fleig Y; Girard J Schweiz Med Wochenschr; 1983 Dec; 113(50):1922-3. PubMed ID: 6420884 [TBL] [Abstract][Full Text] [Related]
14. Appropriate replacement dose of thyroxine in primary hypothyroidism. Frey H; Johannesen O; Kapelrud H; Sand T Acta Med Scand; 1987; 222(2):163-7. PubMed ID: 3673668 [TBL] [Abstract][Full Text] [Related]
15. Dynamics of the plasma concentrations of TSH, FT4 and T3 following thyroxine supplementation in congenital hypothyroidism. Bakker B; Kempers MJ; De Vijlder JJ; Van Tijn DA; Wiedijk BM; Van Bruggen M; Vulsma T Clin Endocrinol (Oxf); 2002 Oct; 57(4):529-37. PubMed ID: 12354136 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus. Celani MF; Bonati ME; Stucci N Diabetes Res; 1994; 27(1):15-25. PubMed ID: 7648793 [TBL] [Abstract][Full Text] [Related]
17. Free thyroid hormones in evaluating persistently elevated thyrotropin levels in children with congenital hypothyroidism on replacement therapy. Focarile F; Rondanini GF; Bollati A; Bartolucci A; Chiumello G J Clin Endocrinol Metab; 1984 Dec; 59(6):1211-4. PubMed ID: 6490797 [TBL] [Abstract][Full Text] [Related]
18. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications. Bayer MF; Kriss JP; McDougall IR J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528 [TBL] [Abstract][Full Text] [Related]
19. Thyrotropin secretion in thyrotoxic and thyroxine-treated patients: assessment by a sensitive immunoenzymometric assay. Spencer CA; Lai-Rosenfeld AO; Guttler RB; LoPresti J; Marcus AO; Nimalasuriya A; Eigen A; Doss RC; Green BJ; Nicoloff JT J Clin Endocrinol Metab; 1986 Aug; 63(2):349-55. PubMed ID: 3088021 [TBL] [Abstract][Full Text] [Related]
20. Thyroid stimulating hormone measurement by an ultrasensitive assay during thyroxine replacement: comparison with other tests of thyroid function. Wheatley T; Clark PM; Clark JD; Raggatt PR; Edwards OM Ann Clin Biochem; 1987 Nov; 24 ( Pt 6)():614-9. PubMed ID: 3122632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]